Aiman Khan

Paraza Pharma is proud to share a recent joint publication

Paraza Pharma is proud to share a recent joint publication in collaboration with Fuzionaire Theranostics, the Departments of Neurology & Neurosurgery and Chemistry at McGill University, and the Department of Chemistry and Chemical Biology at McMaster University

OCCI June 4, 2025

Paraza Pharma will be attending the OCCI conference June 4, 2025, in Ottawa, Ontario.

CSC 2025 Conference

Paraza Pharma will be attending the CSC conference June 15-19, 2025 in Ottawa, Ontario.

AACR Annual Meeting 2025

Paraza Pharma will be exhibiting at the AACR Annual Meeting 2025 taking place April 25-30, 2025, at the McCormick Place Convention Center, Chicago, IL. Come meet us at Booth# 341.

Paraza Pharma Inc. is pleased to announce a recent publication

Paraza Pharma is happy to announce a joint publication with Epics Therapeutics entitled “Discovery, Optimization, and Preclinical Pharmacology of EP652, a METTL3 Inhibitor with Efficacy in Liquid and Solid Tumor Models.”   J. Med. Chem.  2025, ASAP.